SCHEMBL18609471

SCHEMBL18609471

Cc1cccc(F)c1C(=O)N1CCCC(C(=O)Nc2cccc(C(C)(C)C)c2)[C@@H]1c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.41
▸ UBE2M P61081 3/20 0.40
▸ DCUN1D1 Q96GG9 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ EPHX2 P34913 1/20 0.38
▸ TRPV1 Q8NER1 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ PRMT5 O14744 2/20 0.37
▸ WDR77 Q9BQA1 2/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18790219 1.00 HSD17B10 (0.41) HSD17B10UBE2MDCUN1D1ALDH1A1CYP1A2
SCHEMBL12176080 1.00 HSD17B10 (0.41) HSD17B10UBE2MDCUN1D1ALDH1A1CYP1A2
SCHEMBL12074050 0.94 ALDH1A1 (0.43) HSD17B10UBE2MDCUN1D1ALDH1A1CYP1A2
SCHEMBL12176191 0.94 ALDH1A1 (0.43) HSD17B10UBE2MDCUN1D1ALDH1A1CYP1A2
SCHEMBL18790105 0.94 ALDH1A1 (0.43) HSD17B10UBE2MDCUN1D1ALDH1A1CYP1A2
SCHEMBL18532606 0.94 ALDH1A1 (0.43) HSD17B10UBE2MDCUN1D1ALDH1A1CYP1A2
SCHEMBL12160761 0.93 DCUN1D1 (0.48) HSD17B10UBE2MDCUN1D1ALDH1A1EPHX2
SCHEMBL16280646 0.93 DCUN1D1 (0.48) HSD17B10UBE2MDCUN1D1ALDH1A1EPHX2
SCHEMBL18609701 0.93 DCUN1D1 (0.48) HSD17B10UBE2MDCUN1D1ALDH1A1EPHX2
SCHEMBL29726754 0.93 DCUN1D1 (0.48) HSD17B10UBE2MDCUN1D1ALDH1A1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3078658-B1 C5AR ANTAGONISTS CHEMOCENTRYX INC (US) 2019-04-10 — — EP disclosed
US-20170065604-A1 C5aR ANTAGONISTS CHEMOCENTRYX, INC. 2017-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170065604-A1 C5aR ANTAGONISTS C5AR1, C5AR2, C3AR1 HSD17B10 4551/4885UBE2M 4188/4885DCUN1D1 2149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback